FORR:NASDAQForrester Research, Inc. Analysis
Data as of 2026-04-04 - not real-time
$5.48
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
FORR is trading well below its 20‑day and 50‑day moving averages, with the price sinking beneath a clear support zone around $5.30. The MACD histogram is negative and the signal line is bearish, while the RSI sits in the low‑30s, suggesting the stock is oversold but still under downward pressure. Volume has been trending lower, reinforcing the bearish momentum. Recent earnings missed consensus, reporting EPS of $0.17 versus expectations of $0.21, and the company continues to post negative operating margins and a trailing loss per share. Despite these headwinds, management highlighted a rollout of Forrester AI, aiming to modernize its research delivery and capture new subscription revenue.
The discounted cash flow model values the business at roughly $35 per share, implying a massive upside on the current $5.48 price, yet the stark contrast between the DCF and the company’s weak cash conversion, high volatility (over 50% 30‑day), and thin liquidity tempers enthusiasm. The sector’s consulting focus carries modest regulatory exposure, and the firm’s low beta suggests limited market‑wide swings, but the combination of negative earnings, high drawdown, and a shrinking balance sheet flags substantial risk. Investors should weigh the long‑term AI growth narrative against the immediate technical and fundamental deterioration.
The discounted cash flow model values the business at roughly $35 per share, implying a massive upside on the current $5.48 price, yet the stark contrast between the DCF and the company’s weak cash conversion, high volatility (over 50% 30‑day), and thin liquidity tempers enthusiasm. The sector’s consulting focus carries modest regulatory exposure, and the firm’s low beta suggests limited market‑wide swings, but the combination of negative earnings, high drawdown, and a shrinking balance sheet flags substantial risk. Investors should weigh the long‑term AI growth narrative against the immediate technical and fundamental deterioration.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Bearish MACD and price below short‑term moving averages
- Recent earnings miss and negative operating margins
- Decreasing trading volume and proximity to support level
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Launch of Forrester AI could unlock new subscription revenue
- Valuation gap between market price and DCF suggests upside potential
- High volatility and thin liquidity remain concerns
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Long‑term AI integration may drive top‑line growth
- Undervalued relative to industry peers and DCF estimate
- Low beta indicates limited systematic risk over extended horizons
Key Metrics & Analysis
Financial Health
Revenue Growth-6.50%
Profit Margin-30.07%
P/E Ratio6.0
ROE-67.05%
ROA1.27%
Debt/Equity56.82
P/B Ratio0.8
Op. Cash Flow$21.1M
Free Cash Flow$46.3M
Industry P/E28.9
Technical Analysis
TrendBearish
RSI34.1
Support$5.28
Resistance$6.52
MA 20$5.97
MA 50$6.43
MA 200$8.33
MACDBearish
VolumeDecreasing
Fear & Greed Index78.8
Valuation
Fair Value$35.53
Target Price$6.00
Upside/Downside9.49%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.40
Volatility53.98%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.